Abstract Novel immunosuppressants, ushikulides A and B, were isolated from the culture broth of Streptomyces sp. IUK-102. Ushikulides A and B both have the same molecular formula, determined as C 40 H 68 O 10 . The structures of both compounds were elucidated to be novel 22-membered macrolides. Both compounds showed immunosuppressive activity for murine splenocyte proliferation in vitro. Binding of each of these drug-protein complexes to a catalytic subunit of carcineurin causes inhibition of signal transduction in T cell activation [3] . However, these agents have some adverse side-effects such as nephrotoxicity and chronic rejection [4, 5] . Another potent immunosuppressive agent is desired to develop a safer medical treatment. During our screening for immunosuppressants from microbial products, novel immunosuppressants ushikulides A (1) and B (2) were found in the culture broth of Streptomyces sp. IUK-102 (Fig. 1) . This paper describes the isolation, structure elucidation, and biological activities of these compounds.
Japan. This strain was incubated at 27°C for five days in 500-ml Erlenmeyer flasks, each containing 70 ml of medium composed of (NH 4 ) 2 SO 4 0.14%, KH 2 PO 4 0.2%, CaCl 2 0.03%, MgSO 4 · 7H 2 O 0.03%, urea 0.03%, polypepton 0.5%, yeast extracts 0.1%, soybean meal 3%, glucose 1%, soluble starch 0.5%, FeSO 4 · 7H 2 O 0.005%, MnSO 4 · 5H 2 O 0.0016%, ZnSO 4 · 7H 2 O 0.0014%, and CoCl 2 0.002% (pH 7.0 before sterilization). After fermentation on a rotary shaker (230 rpm), four liters of the culture broth was centrifuged to separate mycelia and supernatant. The mycelia were extracted with acetone and the extract was evaporated to give an aqueous residue. This residue was then extracted with EtOAc and the soluble portion was concentrated in vacuo to obtain a brown residue (3.5 g). The residue was subjected to silica gel chromatography and eluted using CHCl 3 followed by a mixture of CHCl 3 and MeOH (90 : 10). Second elution with activity was evaporated and fractionated on a silica gel column using a mixture of CHCl 3 and MeOH (95 : 5). The fractions containing active substrates were combined and concentrated in vacuo. This active material was then subjected to reverse-phase HPLC (CAPCELL PAK C 18 SG 120, Shiseido Co. Ltd., 20ϫ250 mm) using a mixture of CH 3 CN and H 2 O (70 : 30) as the isocratic mobile phase at a flow rate of 5.0 ml/minute. Ushikulides A (1) and B (2) were eluted at 32.1 and 30.0 minutes, respectively. These fractions were collected and concentrated under reduced pressure. Finally, 1 (13 mg) and 2 (5 mg) were obtained as white powders.
Ushikulide A (1) was obtained as a colorless powder with a specific rotation of Ϫ12.7°(c 0.5, MeOH, 25°C). The molecular formula of 1 was established as C 40 (Fig. 2) . Spin systems A and B were connected through a series of HMBC correlations from H-34 to C-9, C-10, and C-11, and from [5.5] undecane, which was fused onto the 22-membered lactone structure. Accordingly, the structure of 1 was determined to be that shown in Fig. 1 . All the assigned proton and carbon signals are listed in Table 1 .
Ushikulide B (2) was obtained as a colorless powder with a specific rotation of Ϫ46.7°(c 0.5, MeOH, 25°C). The molecular formula of 2 was determined to be C 40 H 68 O 10 by HRFAB-MS (found 707.4728, calcd. 707.4734 for M-H), which was the same as that of 1. The IR spectrum (KBr) indicated the presence of hydroxyl and carbonyl groups at 3437 and 1718 cm Ϫ1 , respectively.
Comparison of the 1 H NMR spectra of 2 and 1 revealed that the double bond proton signals at d H 5.60 and d H 5.44 present in 1 were missing in 2. Instead, a proton signal at d H 6.97 was identified in 2.
13 C NMR spectrum of 2 showed four carbon signals at d C 152.2, 149.4, 143.5, and 122.7 attributed to olefinic carbons. The significant difference observed between the NMR spectra resulted from a change in the olefin position. Besides this obvious difference, the 1D NMR spectra of these compounds resembled each other. Additionally, TOCSY and HMBC correlations of 2 (Fig. 3a) suggested that the basal structure of this compound was similar to that of 1, however, more information was still required to establish the structure of 2. Final structure confirmation was accomplished by a ROESY spectrum (Fig. 3b) . The configuration of a double bond composed of C-15 and C-16 was shown to be (E ) from ROESY correlation between H-15 and H-18 (d H 2.31). Correlation of H-27 with H-19 revealed a spiroketal subunit connecting spin systems C and D. Moreover, additional ROESY cross peaks were observed as shown in Fig. 3b . The configuration of the spiroketal in 2 was quite similar to that in cytovaricin [6] , therefore, the structure of 2 was determined as that in Fig. 1 . The complete assignments of proton and carbon signals in 1 and 2 revealed the considerable difference of proton chemical shifts of H 2 -18 between these compounds (Table 1) . This suggested that the positional change of the olefin near the ketone group caused a conformation of 22-membered lactone ring to be changed. As a result, H 2 -18 at d H 2.31 and 3.60 in 2 were placed in a shielding area of the ketone group and a deshielding area of the ketone group, respectively. The immunosuppressive activities of these compounds were estimated by concanavalin A (ConA) stimulated lymphocyte blastogenesis [7] . Both compounds inhibited murine splenic lymphocyte proliferation with IC 50 values of 70 nM, comparable to that of cyclosporin A. Compounds 1 and 2 did not show significant cytotoxicity for KB cells at a concentration of 10 m M.
Ushikulides A (1) and B (2) are related to phthoramycin [8] , kaimonolide A [9] , and the aglycone of cytovaricin [6, 10] , which are thought to be members of the oligomycin family from the point of view of biosynthesis. Oligomycin F [11] and 41-demethylhomooligomycin B [12] , which have a 26-membered lactone ring in their structures, are known to possess immunosuppressive activities. As far as we know, this is the first report describing a 22-membered macrolide with a spiroketal moiety that shows immunosuppressive activity. 
